The WHO categorized ASHUE cases as either confirmed (not applicable at present), probable (“person presenting with an acute hepatitis (non hepA-E*) with serum transaminase > 500 IU/L (AST or ALT), who is 16 years and younger, since 1 October 2021”), and epi-linked cases (“a person presenting with an acute hepatitis (non hepA-E*) of any age who is a close contact of a probable case, since 1 October 2021”) [1, 3]. The gene discussed is GPT; the disease is Acute hepatitis.